{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:06:58Z","timestamp":1773234418368,"version":"3.50.1"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jocn-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jocn.2017.06.048","type":"journal-article","created":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T16:00:49Z","timestamp":1499270449000},"page":"243-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Bilateral retrobulbar optic neuropathy as the only sign of zoledronic acid toxicity"],"prefix":"10.1016","volume":"44","author":[{"given":"F\u00e9lix Manco","family":"Lavado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta Para","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Rosalba Ramoa","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Isabel L\u00f3pez","family":"G\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda Manzanas","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2017.06.048_b0005","unstructured":"Summary of Product Characteristics: Zometa. Available from: http:\/\/www.medicines.org.uk\/emc."},{"key":"10.1016\/j.jocn.2017.06.048_b0010","unstructured":"Zometa. Prescribing Information. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2001\/21223lbl.pdf."},{"key":"10.1016\/j.jocn.2017.06.048_b0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0039-6257(97)00130-6","article-title":"Drug-induced uveitis","volume":"42","author":"Moorthy","year":"1998","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jocn.2017.06.048_b0020","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3129\/i09-110","article-title":"Orbital inflammation and optic neuropathy with zoledronic acid for metastatic prostate cancer","volume":"44","author":"Seth","year":"2009","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jocn.2017.06.048_b0025","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJM199903043400914","article-title":"Gamma\/delta T-cell stimulation by pamidronate","volume":"340","author":"Kunzmann","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2017.06.048_b0030","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.clon.2012.12.006","article-title":"Zolendronic acid-induced retrobulbar optic neuritis: a case report","volume":"25","author":"Brulinski","year":"2013","journal-title":"Clin Oncol (R Coll Radiol)"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817306197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817306197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T15:20:32Z","timestamp":1535642432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586817306197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":6,"alternative-id":["S0967586817306197"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2017.06.048","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bilateral retrobulbar optic neuropathy as the only sign of zoledronic acid toxicity","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2017.06.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}